GATC Biotech AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:GATC Biotech AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014175
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GATC Biotech AG (GATC Biotech) is a healthcare service center that offers sequencing services. The center products category include nextgen, liquid biopsy, tissue biopsy, sanger and cell culture. It offers nextgen products such as inview transcriptome, inview metagenome, inview microbiome, inview amplicon, inview de novo genome, inview modification analysis and inview epigenome. GATC Biotech provides Sanger sequencing services such as SUPREMErun, LIGHTrun sequencing, and NightXpress services. The center solutions include sequencing solutions, customized solutions and diagnostic solutions. It serves academic and industrial customers worldwide. Its partner portfolio includes Agilent Technologies, Applied Biosystems, BioLago, Cytobox, Roche, Illumina, Trenzyme and Macherey-Nagel. The company distributes its products in Italy, Japan, Portugal, Spain Turkey and Czech Republic. GATC is headquartered in
Constance, Germany.

GATC Biotech AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GATC Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GATC Biotech AG, Medical Devices Deals, 2011 to YTD 2017 8
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
GATC Biotech AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
GATC Biotech Enters into Agreement with University of Konstanz 10
Qiagen Enters into Agreement with GATC Biotech 11
Acquisition 12
Eurofins Scientific to Acquire GATC Biotech 12
GATC Biotech AG – Key Competitors 13
GATC Biotech AG – Key Employees 14
GATC Biotech AG – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
Jun 09, 2016: Liquid biopsy test – GATCLIQUID ONCOTARGET – expanded to cover blood cancers such as acute myeloid leukaemia 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
GATC Biotech AG, Pharmaceuticals & Healthcare, Key Facts 2
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GATC Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GATC Biotech AG, Medical Devices Deals, 2011 to YTD 2017 8
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
GATC Biotech Enters into Agreement with University of Konstanz 10
Qiagen Enters into Agreement with GATC Biotech 11
Eurofins Scientific to Acquire GATC Biotech 12
GATC Biotech AG, Key Competitors 13
GATC Biotech AG, Key Employees 14
GATC Biotech AG, Other Locations 15
GATC Biotech AG, Subsidiaries 15

★海外企業調査レポート[GATC Biotech AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析
    Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Campofrio Food Group, S.A.:戦略・SWOT・企業財務分析
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • BioChain Institute Inc-医療機器分野:企業M&A・提携分析
    Summary BioChain Institute Inc (BioChain) is a medical device company that designs, develops and markets diagnostic products. The company provides processed bio-sample products and analysis services used in translational medicine, companion diagnostics, and clinical product research and development. …
  • Oracle Corporation Japan (4716):企業の財務・戦略的SWOT分析
    Summary Oracle Corporation Japan (Oracle Corp) is an information technology company that offers software and hardware services. The company offers integrated cloud applications and platform services. It develops software and hardware products, solutions, consulting, support services, education busin …
  • AirAsia Berhad:企業のM&A・事業提携・投資動向
    AirAsia Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AirAsia Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Engie Brasil Energia SA (EGIE3):電力:M&Aディール及び事業提携情報
    Summary Engie Brasil Energia SA (Engie Brasil), formerly Tractebel Energia SA, a subsidiary of Engie SA, undertakes the generation and commercialization of electricity. It generates energy through various source of energy such as hydro; thermal; and complementary energy sources including wind, solar …
  • Ad Scientiam:企業の製品パイプライン分析
    Summary Ad Scientiam is a medical technology company that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare profes …
  • QRxPharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary QRxPharma Ltd (QRxPharma) develops and commercializes treatments for pain management and abuse prevention products. The company’s product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR (Q8003), an immediate release oral …
  • Schiller AG:企業の戦略的SWOT分析
    Schiller AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Daiwa Can Co., Ltd.:企業の戦略・SWOT・財務情報
    Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Layne Christensen Co (LAYN):石油・ガス:M&Aディール及び事業提携情報
    Summary Layne Christensen Company (Layne) is a water management, construction and drilling company. It provides solutions to essential natural resources such as water, mineral and energy. The company’s service portfolio includes hydrological studies, site selection, well design, drilling, well rehab …
  • Gordon Food Service Inc:企業の戦略的SWOT分析
    Gordon Food Service Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Agri-Industries Holdings Ltd (606):企業の財務・戦略的SWOT分析
    China Agri-Industries Holdings Ltd (606) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • IBC Solar AG:電力:M&Aディール及び事業提携情報
    Summary IBC Solar AG (IBC Solar), formerly IBC Solartechnik, is a solar energy company that provides photovoltaic and energy storage solutions and services. The company’s product range includes solar parks, self-consumption systems for commercial enterprises and private households, diesel hybrid sol …
  • Nestle (Malaysia) Bhd:戦略・SWOT・企業財務分析
    Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report Summary Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Avid Bioservices Inc (CDMO):製薬・医療:M&Aディール及び事業提携情報
    Summary Avid Bioservices Inc (Avid Bioservices), formerly Peregrine Pharmaceuticals Inc, is a biopharmaceutical company that develops, manufactures and markets monoclonal antibodies for the treatment and diagnosis of cancer. The company’s products include Bavituximab, PGN650 and Cotara. Its Bavituxi …
  • KitCheck Inc:医療機器:M&Aディール及び事業提携情報
    Summary KitCheck Inc (KitCheck) is a provider of automated hospital pharmacy kit processing and medication tracking software solution. The company’s Kit Check is an automated medication tray management system based on scalable cloud software platform uses RFID tags to track each medication that help …
  • Youlchon Chemical Co Ltd:企業の戦略・SWOT・財務情報
    Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆